Head-To-Head Review: Pediatrix Medical Group (NYSE:MD) & NewGenIvf Group (NASDAQ:NIVF)

Pediatrix Medical Group (NYSE:MD) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, dividends, earnings, institutional ownership and risk.

Volatility & Risk

Pediatrix Medical Group has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of -0.07, suggesting that its stock price is 107% less volatile than the S&P 500.

Profitability

This table compares Pediatrix Medical Group and NewGenIvf Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Pediatrix Medical Group	9.02%	19.94%	8.02%
NewGenIvf Group	N/A	N/A	N/A

Institutional and Insider Ownership

97.7% of Pediatrix Medical Group shares are owned by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are owned by institutional investors. 1.8% of Pediatrix Medical Group shares are owned by company insiders. Comparatively, 31.8% of NewGenIvf Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings for Pediatrix Medical Group and NewGenIvf Group, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pediatrix Medical Group	0	5	1	0	2.17
NewGenIvf Group	1	0	0	0	1.00

Pediatrix Medical Group presently has a consensus target price of $22.50, indicating a potential downside of 4.32%. Given Pediatrix Medical Group’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Pediatrix Medical Group is more favorable than NewGenIvf Group.

Earnings and Valuation

This table compares Pediatrix Medical Group and NewGenIvf Group”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pediatrix Medical Group	$1.91 billion	1.01	$165.39 million	$2.06	11.42
NewGenIvf Group	$4.73 million	0.04	$9.88 million	N/A	N/A

Pediatrix Medical Group has higher revenue and earnings than NewGenIvf Group.

Summary

Pediatrix Medical Group beats NewGenIvf Group on 11 of the 12 factors compared between the two stocks.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

About NewGenIvf Group

NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company was founded by Siu Wing Fung and Fong Hei Yue on January 16, 2019 and is headquartered in Bangkok, Thailand.